Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Funding Both studies were funded by Novo Nordisk A/S and are registered with ClinicalTrials.gov (NCT04209049 and NCT05564104)
For the majority of patients, GLP-1-related stomach pain resolves within 48 weeks as the body develops tolerance to the medication's effects
HumeCare's Terms are governed by the substantive law of the State of New York
First, we leveraged a large, geographically diverse real-world database spanning multiple US health systems, enabling the evaluation of treatment effectiveness in a clinically relevant population of adults treated specifically for obesity managementrather than glycaemic control
US$ 23.11
US$ 21.68
US$ 28.83
US$ 27.67
